Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate for depression in hospice practice: a case series.

J Homsi1, D Walsh, K A Nelson

  • 1The Harry R. Horvitz Center for Palliative Medicine, The Cleveland Clinic Taussig Cancer Center, Ohio, USA.

The American Journal of Hospice & Palliative Care
|March 12, 2002
PubMed
Summary

Methylphenidate effectively treated depression in advanced cancer patients, showing rapid symptom relief. This psychostimulant also improved appetite, concentration, and fatigue with no severe side effects observed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiologic, Histologic and Scanning Electron Microscopic Characterization of the Peritoneal Reflection in Crohn's Disease.

Clinical anatomy (New York, N.Y.)·2026
Same author

Anaesthesia for caesarean delivery in patients with placenta accreta spectrum: a retrospective cohort study in two referral centres in Ireland (2017-2024).

International journal of obstetric anesthesia·2026
Same author

Objective measurement of cancer-related fatigue.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Epilepsy and Employment in Europe: A Systematic Review of Literature.

European journal of neurology·2025
Same author

Explanations for higher-than-expected all-cause mortality from April 2021: A scoping review.

Public health·2024
Same author

Sputum culture contamination and associated characteristics in a diagnostic clinical trial, Papua New Guinea.

Public health action·2024

Area of Science:

  • Oncology
  • Psychiatry
  • Pharmacology

Background:

  • Depression is a common comorbidity in advanced cancer patients.
  • Psychostimulants are explored as a treatment option for cancer-related depression.
  • Methylphenidate is a psychostimulant with potential antidepressant properties.

Observation:

  • The study observed the effects of methylphenidate in 10 consecutive patients with advanced cancer experiencing depression.
  • The onset of methylphenidate's therapeutic effect was noted to be rapid.
  • Improvements in associated symptoms like appetite, concentration, fatigue, and sedation were also monitored.

Findings:

  • Methylphenidate demonstrated successful treatment of depression in this cohort of advanced cancer patients.
  • A rapid onset of action was a key finding in the observed cases.

Related Experiment Videos

  • Some patients experienced improvements in appetite, concentration, fatigue, and sedation.

    • Implications:

    • Methylphenidate may be a viable and effective treatment option for depression in advanced cancer patients.
    • The rapid onset of action suggests potential for timely symptom management.
    • Further research is warranted to confirm these findings in larger, controlled studies.